Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

KRISHGEN BIOSYSTEMS Immunoassay for the quantitative determination of Anti-Adalimumab antibodies in human serum and plasma. Assay Range: 20 - 640 ng/ml; Sensitivity: 18 ng/ml.

Supplier:  KRISHGEN BIOSYSTEMS KBI2015

Encompass_Preferred

Pack Size: 1 x 96 wells. This Anti-Adalimumab ELISA accurately quantifies antibodies to adalimumab in human samples. If you are looking to use animal samples, please contact us. Introduction: Adalimumab is a TNF-inhibiting, anti-inflammatory, biologic medication. It binds to tumor necrosis factor-alpha (TNF alpha), which normally binds to TNF alpha receptors, leading to the inflammatory response of autoimmune diseases. By binding to TNF alpha adalimumab reduces this inflammatory response, as it is also part of the immune system, which protects the body from infection, treatment with adalimumab may increase the risk of infections. Validated against ICH M10 guidelines for bioassays. ELISA Features include a pre-coated plate with break-apart wells, standardisation and Precision CV <10%.

Catalog No. NC2747140


May include imposed supplier surcharges.
Only null left
Add to Cart

Description

Description

Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title
KRISHGEN BIOSYSTEMS Immunoassay for the quantitative determination of Anti-Adalimumab antibodies in human serum and plasma. Assay Range: 20 - 640 ng/ml; Sensitivity: 18 ng/ml.

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.